Latest filing published 23 Mar 2022 for Epigral Limited, €8,823.
Dhiren Madhur Goyal appears in our data through filings on Epigral Limited shares, published by SEBI (PIT + SAST). Over a trading history stretching from 29 November 2021 to 17 December 2021, the count stands at 4 filings.
On the market, this insider has only ever bought: 4 purchases, €42k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2022 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €8,860. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 23 March 2022 came the latest disclosure, an open-market purchase for €8,823 in Epigral Limited. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations